Magdalena O. Cilella Ph.D.
Patent Agent

Magdalena Cilella's intellectual property law practice focuses on patent law matters related to molecular/cell biology, pharmaceuticals and biotechnology. Specifically, Magda has assisted clients with preparation and prosecution of patent applications relating to variety of technologies, including diagnostics, proteins, pharmaceuticals and cosmeceuticals, cell-based assays, plants and medical devices.

Magda brings to the firm a strong research background including experiences in neurodegeneration and tauopathies, specializing in intransglutaminase-induced cross-linking in progressive supranuclear palsy and the effects of Echinacea (over-the-counter dietary supplement) on the human immune system.

Practice Groups
Education
  • Ph.D., Pharmacology and Experimental Therapeutics
    , 2002
  • B.A., Biology and Pre-Medicine, cum laude
    Augustana College, 1997
Bar Admissions
  • U.S. Patent & Trademark Office
Technical Background
  • Biopharma
Languages
  • Polish
  • Russian
Experience | Legal

Brinks Gilson & Lione, Chicago, Illinois
Scientific Advisor, 2002-Present

Experience | Teaching

Loyola University Chicago, Maywood, Illinois
Teaching Fellow, 2000-2002
Principles of Pharmacology (graduate level course)

Presentations
  • "Involvement of Transglutaminase Enzyme in Progressive Supranuclear Palsy," co-presenter, Society for Neuroscience Chicago Chapter, Chicago, Illinois
Honors
  • Student Speaker Representative, Chicago Chapter for Neuroscience Annual Scientific Meeting, Loyola University Chicago, 2001
  • Arthur J. Schmitt Dissertation Fellowship for outstanding academic achievements and in recognition of the scholarly promise of the proposed dissertation research, 2000
  • Great Lakes Chapter/American Society for Pharmacology and Experimental Therapeutics, 3rd place award (poster presentation), 2000
Affiliations
  • Society for Neuroscience
  • American Society for Pharmacology and Experimental Therapeutics
  • American Association for the Advancement of Science
  • Intellectual Property Owners Association
Back to Top